Cervical Cancer: Open Access
Open Access

Cervical cancer; Human papillomavirus; HPV; Screening; Pap smear; HPV vaccine; Molecular mechanisms; Biomarkers; Early detection; Prevention; Treatment; Global health; Women's health; Gynecological cancer

Introduction

Cervical cancer is a significant health concern that affects women worldwide. It develops in the cervix, the lower part of the uterus that connects to the vagina. The primary cause of cervical cancer is persistent infection with certain types of human papillomavirus (HPV) [1]. While cervical cancer is a serious condition, it is also highly preventable and treatable, especially when detected in its early stages through regular screenings [2]. Cervical cancer stands as a significant global health concern, impacting the lives of women around the world. This malignancy arises from the cells of the cervix, the lower part of the uterus connecting to the vagina. Human papillomavirus (HPV) infection is the primary risk factor for the development of cervical cancer, making it a preventable and treatable disease with appropriate interventions [3,4].

This form of cancer represents a complex interplay of biological, social, and economic factors [5]. While advancements in medical science have led to improved screening methods and effective vaccines against HPV, the burden of cervical cancer remains unevenly distributed, with higher incidence rates in low-resource settings. The implications of cervical cancer extend beyond the physical health of individuals, impacting psychological well-being, relationships, and societal productivity [6,7]. As we delve into the intricate landscape of cervical cancer, it becomes crucial to understand the multifaceted dimensions of its causation, progression, prevention, and treatment [8]. In this comprehensive exploration, we will navigate through the epidemiology of cervical cancer, its association with HPV, the role of early detection through screening programs, the impact on global health disparities, and the ongoing efforts to enhance prevention and treatment strategies [9,10].

Causes and risk factors

Human papillomavirus (HPV): HPV is the leading cause of cervical cancer. There are over 100 types of HPV, but only a few highrisk types, such as HPV 16 and 18, significantly increase the risk of cervical cancer. HPV is a sexually transmitted infection, and most sexually active individuals will contract it at some point in their lives. However, the immune system can often clear the infection on its own.

Weakened immune system: Individuals with weakened immune systems, whether due to conditions like HIV/AIDS or immunosuppressive medications, are at an increased risk of developing cervical cancer.

Smoking: Tobacco use, particularly smoking, is a known risk factor for cervical cancer. Smoking may contribute to the persistence of HPV infection and increase the likelihood of cervical cancer development.

Long-term use of birth control pills: Women who have used oral contraceptives for an extended period may have a slightly increased risk of cervical cancer. However, this risk diminishes once the pills are discontinued.

Symptoms

In the early stages, cervical cancer may not cause noticeable symptoms. As the disease progresses, the following symptoms may occur:

Abnormal vaginal bleeding: This includes bleeding between periods, after intercourse, or after menopause.

Pelvic pain: Discomfort or pain during intercourse and pelvic pain unrelated to menstrual cycles may be indicative of cervical cancer.

Unusual vaginal discharge: A change in the colour, smell, or consistency of vaginal discharge can be a symptom.

Prevention

HPV vaccination: Vaccination against HPV is a crucial preventive measure. The HPV vaccine is most effective when administered before the onset of sexual activity.

Regular Pap Smears: Pap smears or Pap tests are crucial for detecting abnormal cervical cells early, before they become cancerous. The recommended frequency of Pap smears may vary depending on factors such as age and previous test results.

Safe sexual practices: Practicing safe sex, including the use of condoms, can reduce the risk of HPV transmission.

Smoking cessation: Quitting smoking is essential for overall health and can also lower the risk of cervical cancer.

Treatment

Treatment options for cervical cancer depend on the stage of the disease and may include:

Surgery: Surgical procedures may involve the removal of the abnormal cells, the cervix (radical hysterectomy), or more extensive surgery for advanced stages.

Radiation therapy: High-energy rays are used to target and destroy cancer cells.

Chemotherapy: Medications are used to kill cancer cells or stop their growth.

Targeted therapy: Drugs that specifically target certain molecules involved in cancer growth may be used.

Conclusion

Cervical cancer is a significant global health issue, but with advancements in preventive measures, early detection, and treatment options, the prognosis for affected individuals has improved. Regular screenings, vaccination against HPV, and lifestyle changes can significantly reduce the risk of developing cervical cancer. It is essential for individuals to be aware of the importance of cervical health and to engage in proactive measures to protect themselves and their communities. Cervical cancer, though a formidable adversary, is not an insurmountable challenge. The strides made in research, education, and healthcare infrastructure has transformed this disease from a silent threat to a battlefront where progress is palpable. The integration of HPV vaccination programs, widespread screening initiatives, and advancements in treatment modalities has reshaped the landscape of cervical cancer prevention and care.

However, the journey towards eradicating cervical cancer is far from complete. Disparities in access to healthcare, education, and resources persist, creating pockets of vulnerability where the burden of this disease remains disproportionately high. Bridging these gaps requires a concerted effort from governments, healthcare professionals, researchers, and society as a whole.

The empowerment of women through education, awareness, and access to preventive measures is central to this mission. Through collective action, we can aspire to relegate cervical cancer to the pages of medical history, ensuring a healthier and brighter future for generations to come.

1. Hull M (2016) Medical language proficiency:A discussion of interprofessional language competencies and potential for patient riskInt J Nurs Stud 54: 158-172.

Indexed at, Google Scholar, Crossref

2. Kheder S, Kaan E (2021)Cognitive control in bilinguals: Proficiency and code-switching both matterCognition 209: 104575.

Indexed at, Google Scholar, Crossref

3. Schwab SM, Dugan S, Riley MA (2021)Reciprocal Influence of Mobility and Speech-Language: Advancing Physical Therapy and Speech Therapy Cotreatment and Collaboration for AdultsWith Neurological Conditions. Phys Ther 101: pzab196.

Indexed at, Google Scholar, Crossref

4. Barratt J, Littlejohns P, Thompson J (1992)Trial of intensive compared with weekly speech therapy in preschool children. Arch Dis Child 67: 106-108.

Indexed at, Google Scholar, Crossref

5. Hoben K, Varley R, Cox R (2010)Clinical reasoning skills of speech and language therapy students. Int J Lang Commun Disord 1: 123-235.

Indexed at, Google Scholar, Crossref

6. Scott S, Caird FI (1983)Speech therapy for Parkinson's disease. J Neurol Neurosurg Psychiatry 46:140-144.

Indexed at, Google Scholar, Crossref

7. Ygual-Fernández A, Cervera-Mérida JF, Rosso P (2008)The value of phonological analysis in speech therapy. Rev Neurol 1: S97-100.

Indexed at, Google Scholar

8. Freud D, Ezrati-Vinacour R, Amir O (2018)Speech rate adjustment of adults during conversation.J Fluency Disord 57: 1-10.

Indexed at, Google Scholar, Crossref

9. Hill AE, Davidson BJ, Theodoros DG (2012)Reflections on clinical learning in novice speech-language therapy students.Int J Lang Commun Disord 47: 413-426.

Indexed at, Google Scholar, Crossref

10. Furlong L, Erickson S, Morris ME (2010)Computer-based speech therapy for childhood speech sound disorders. J Commun Disord 68: 50-69.

Indexed at, Google Scholar, Crossref